DOCETAXEL , PACLITAXEL , KEYTRUDA 25 mg/mL concentrate for solution for infusion, CAPECITABINE , CETUXIMAB, Lenvatinib, Lenvatinib
MK-7902-009
Phase 2 small_molecule active
Quick answer
DOCETAXEL , PACLITAXEL , KEYTRUDA 25 mg/mL concentrate for solution for infusion, CAPECITABINE , CETUXIMAB, Lenvatinib, Lenvatinib for Recurrent or metastatic squamous cell carcinoma of the head and neck is a Phase 2 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Recurrent or metastatic squamous cell carcinoma of the head and neck
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active